All Clinical Trials

A listing of 23174 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Evaluation of Wear Experience With a Weekly Replacement Soft Contact Lens in Neophyte Lens Wearers With Astigmatism

NCT06751225

Recruiting

This open-label study is of adults with astigmatism who have never worn contact lenses. Subjects will be fit into a one week planned-replacement contact lenses and will wear lenses for approximately 3 weeks. Subjects will return for vision and lens fit assessments and will complete surveys about their wear experience.

Gender:

ALL

Ages:

Between 18 years and 40 years

Trial Updated:

07/17/2025

Locations: The Ohio State University College of Optometry, Columbus, Ohio

Conditions: Astigmatism Bilateral

Learn More ›

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

NCT06750094

Recruiting

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, and irinotecan hydrochloride (FOLFIRI) versus either cetuximab or bevacizumab and FOLFIRI given to participants with Kirsten rat sarcoma viral oncogene/ neuroblastoma RAS viral oncogene homolog (K... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/17/2025

Locations: Ironwood Cancer and Research Center, Chandler, Arizona +191 locations

Ironwood Cancer and Research Center, Chandler, Arizona

Arizona Oncology Associates PC NAHOA, Prescott, Arizona

St. Bernard's Medical Center, Jonesboro, Arkansas

CBCC Global Research, Bakersfield, California

Los Angeles Cancer Network, Glendale, California

Cancer and Blood Specialty Clinic, Los Alamitos, California

USC Norris Comprehensive Cancer Center, Los Angeles, California

Providence Medical Foundation, Santa Rosa, California

Torrance Memorial Physicians Network, Torrance, California

University of Colorado Denver Anschultz Medical Campus, Aurora, Colorado

Rocky Mountain Cancer Centers, Denver, Colorado

Eastern Connecticut Hematology & Oncology Assoc., Norwich, Connecticut

Florida Cancer Specialists South, Fort Myers, Florida

Mount Sinai Medical Center Campus, Miami Beach, Florida

AdventHealth Cancer Institute, Orlando, Florida

Florida Cancer Specialists North Region, Saint Petersburg, Florida

Florida Cancer Specialists East, West Palm Beach, Florida

Grady Memorial Hospital, Atlanta, Georgia

Piedmont Cancer Institute, Atlanta, Georgia

Winship Cancer Institute Emory University, Atlanta, Georgia

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

MedStar Franklin Square Medical Center, Baltimore, Maryland

Cancer And Hematology Centers of Western Michigan PC, Grand Rapids, Michigan

Hattiesburg Clinic, Hattiesburg, Mississippi

Washington University School Of Medicine, Saint Louis, Missouri

Nebraska Cancer Specialists, Omaha, Nebraska

Astera Cancer Care, East Brunswick, New Jersey

Montefiore Einstein Comprehensive Cancer Center, Bronx, New York

Perlmutter Cancer Center at NYU Long Island, Mineola, New York

NYU Langone Medical Center NYU Hematology Associates, New York, New York

New York Cancer and Blood Specialists, Shirley, New York

University Hospital of Cleveland, Cleveland, Ohio

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Tennessee Oncology, Chattanooga, Tennessee

SCRI Oncology Partners, Nashville, Tennessee

Tennessee Oncology, Nashville, Tennessee

Texas Oncology West Texas, Abilene, Texas

Texas Oncology DFW, Dallas, Texas

MD Anderson Cancer Center, Houston, Texas

Texas Oncology - San Antonio, San Antonio, Texas

Scott And White Memorial Hospital, Temple, Texas

Providence Regional Cancer System, Lacey, Washington

Concord Hospital, Concord, Not set

Warringal Private Hospital, Heidelberg, Not set

Queen Elizabeth Hospital, South Woodville, Not set

Western Health Sunshine Hospital, St Albans, Not set

Institut Jules Bordet, Anderlecht, Not set

UZ Antwerpen, Edegem, Not set

AZ Maria Middelares, Gent, Not set

Jolimont, Haine Saint Paul La Louviere, Not set

Az Groeninge, Kortrijk, Not set

Universitair Ziekenhuis Leuven, Leuven, Not set

Fundacao Pio XII, Barretos, Not set

Fundacao Universidade de Caxias do Sul, Caxias do Sul, Not set

Fundacao Doutor Amaral Carvalho, Jau, Not set

Hospital Santa Izabel Santa Casa de Misericordia da Bahia, Salvador, Not set

Fundacao Faculdade Regional De Medicina S Jose Rio Preto Hospital De Base, Sao Jose do Rio Preto, Not set

Fundacao Antonio Prudente A C Camargo Cancer Center, Sao Paulo, Not set

Associacao Feminina de Educacao e Combate ao Cancer Hospital Santa Rita de Cassia, Vitoria, Not set

Peking University First Hospital, Beijing, Not set

Beijing Friendship Hospital Capital Medical University, Beijing, Not set

Beijing Cancer Hospital, Beijing, Not set

The First Bethune Hospital of Jilin University, Changchun, Not set

West China Hospital of Sichuan University, Chengdu, Not set

Ganzhou Cancer Hospital, Ganzhou, Not set

Sun Yat Sen University Cancer Center, Guangzhou, Not set

The Sixth Affiliated Hospital Sun Yat sen University, Guangzhou, Not set

Guangdong Provincial People's Hospital, Guangzhou, Not set

The Second Affiliated Hospital of Zhejiang University, Hangzhou, Not set

Zhejiang Cancer Hospital, Hangzhou, Not set

Harbin medical university cancer hospital, Harbin, Not set

Huizhou Central People's Hospital, Huizhou, Not set

Gansu Provincial Cancer Hospital, Lanzhou, Not set

The First Affiliated Hospital of NanChang University, Nanchang, Not set

Fudan University Shanghai Cancer Center, Shanghai, Not set

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Not set

Hubei Cancer Hospital, Wuhan, Not set

Institut Sainte Catherine, Avignon Cedex 9, Not set

Hopital Haut Leveque, Pessac, Not set

CHU De Poitiers, Poitiers Cedex, Not set

Charite Universitatsmedizin Berlin Campus Virchow Klinikum, Berlin, Not set

Krankenhaus NorthWest, Frankfurt am Main, Not set

National Center for Tumor Diseases NCT, Heidelberg, Not set

Klinikum der Universitaet Muenchen, Munich, Not set

Queen Mary Hospital, Hong Kong, Not set

Prince Of Wales Hospital, Shatin, Not set

Markhot Ferenc Oktatokorhaz es Rendelointezet, Eger, Not set

Pecsi Tudomanyegyetem, Pecs, Not set

Rajiv Gandhi Cancer Institute and Research Centre, Delhi, Not set

Asian Institute Of Gastroenterology, Hyderabad, Not set

B P Poddar Hospital and Medical research Limited, Kolkata, Not set

Tata Memorial Hospital, Mumbai, Not set

Deenanath Mangeshkar Hospital and Research Centre, Pune, Not set

Mahamana Pandit Madan Mohan Malviya Cancer Centre, Varanasi, Not set

Christian medical, Vellore, Not set

Yitzhak Shamir Medical Center, Beer Yaakov, Not set

Rambam Medical Center, Haifa, Not set

Hadassah Medical Center, Jerusalem, Not set

Rabin Medical Center, Petach Tikva, Not set

Sheba Medical Center, Ramat Gan, Not set

Tel Aviv Sourasky Medical Center, Tel Aviv Yafo, Not set

Assuta MC, Tel Aviv, Not set

Istituto Dei Tumori Di Milano, Milano, Not set

Istituto Oncologico Veneto - IRCCS, Padova, Not set

Azienda Ospedaliero Universitaria Pisana, Pisa, Not set

Istituto Clinico Humanitas, Rozzano, Not set

Azienda Sanitaria Universitaria Friuli Centrale ASU FC, Udine, Not set

Chiba Cancer Center, Chiba, Not set

National Cancer Center Hospital, Chuo Ku, Not set

National Cancer Center Hospital East, Kashiwa, Not set

Aichi Cancer Center, Nagoya Shi, Not set

Osaka International Cancer Institute, Osaka City, Not set

Kindai University Hospital, Osaka Sayama shi, Not set

National Hospital Organization Osaka National Hospital, Osaka-Shi, Not set

Shizuoka Cancer Center, Shizuoka, Not set

Osaka University Hospital, Suita-shi, Not set

The Cancer Institute Hospital of JFCR, Tokyo, Not set

Kyungpook National University Chilgok Hospital, Daegu, Not set

Korea University Anam Hospital, Seoul, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System, Seoul, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

The Catholic University of Korea Seoul St Mary s Hospital, Seoul, Not set

Hospital Pulau Pinang, Georgetown, Not set

Hospital Raja Permaisuri Bainun, Ipoh, Not set

Hospital Kuala Lumpur, Kuala Lumpur, Not set

University Malaya Medical Centre, Kuala Lumpur, Not set

Hospital Umum Sarawak, Kuching, Not set

Institut Kanser Negara Clinical Research Center, Putrajaya, Not set

Centro Oncologico de Chihuahua, Chihuahua, Not set

Centro Oncologico Personalizado Cope S De R L De C V, Ciudad de Mexico, Not set

Actualidad Basada En La Investigacion Del Cancer, Guadalajara, Not set

Oncocenter, Puebla, Not set

Cuidados Oncologicos, Queretaro, Not set

Health Pharma Queretaro SA de CV, Queretaro, Not set

COI Centro Oncologico Internacional Tijuana, Tijuana, Not set

Meander Medisch Centrum, Amersfoort, Not set

Radboud University Medical Center, Nijmegen, Not set

Erasmus MC, Rotterdam, Not set

ETZ TweeSteden, Tilburg, Not set

Wojewodzki Szpital Specjalistyczny, Biala Podlaska, Not set

Bialostockie Centrum Onkologii im Marii Sklodowskiej Curie w Bialymstoku, Bialystok, Not set

Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza, Brzozow, Not set

Uniwersyteckie Centrum Kliniczne, Gdansk, Not set

Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut BadawczyOddz w Gliwicach, Gliwice, Not set

Instytut Centrum Zdrowia Matki Polki, Lodz, Not set

SPZOZ Ministerstwa Spraw Wewnetrznych z Warminsko Mazurskim Centrum Onkologii w Olsztynie, Olsztyn, Not set

SPZOZ Opolskie Centrum Onkologii im. Prof. Tadeusza Koszarowskiego, Opole, Not set

Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warszawa, Not set

Pan American Center for Oncology Trials LLC, San Juan, Not set

Centrul Medical Unirea SRL, Brasov, Not set

Ponderas Academic Hospital, Bucuresti, Not set

Clinica de Oncologie Sf Nectarie, Craiova, Not set

Hosp. de La Santa Creu I Sant Pau, Barcelona, Not set

Hosp Univ Vall D Hebron, Barcelona, Not set

Hosp. Gral. Univ. Gregorio Maranon, Madrid, Not set

Hosp. Univ. Ramon Y Cajal, Madrid, Not set

Hosp. Univ. 12 de Octubre, Madrid, Not set

Clinica Univ. de Navarra, Pamplona, Not set

Hosp. Virgen Del Rocio, Sevilla, Not set

Hosp. Clinico Univ. de Valencia, Valencia, Not set

Sahlgrenska Universitetssjukhuset, Gothenburg, Not set

Skanes universitetssjukhus, Lund, Not set

Sodersjukhuset, Stockholm, Not set

Karolinska Universitetssjukhuset, Stockholm, Not set

Uppsala University, Uppsala, Not set

Chang Gung Memorial Hospital, Kaohsiung City, Not set

Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung, Not set

Taichung Veterans General Hospital, Taichung, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Linkou Chang Gung Memorial Hospital, Taoyuan, Not set

Ramathibodi Hospital, Bangkok, Not set

Siriraj Hospital, Bangkok, Not set

Chiang Mai University, Chiang Mai, Not set

Songklanagarind hospital, Songkhla, Not set

Adana City Hospital, Adana, Not set

Gulhane Egitim ve Arastirma Hastanesi, Ankara, Not set

Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Not set

Gazi University Hospital, Ankara, Not set

Bakirkoy Training and Research Hospital, Istanbul, Not set

Marmara University Pendik Training Hospital, İstanbul, Not set

Necmettin Erbakan University Meram Medical Faculty, Konya, Not set

Sakarya University Training and Research Hospital, Sakarya, Not set

Castle Hill Hospital, Hull, Not set

St James University Hospital, Leeds, Not set

St Bartholomew's Hospital, London, Not set

University College Hospital, London, Not set

Royal Marsden Hospital, London, Not set

Mount Vernon Cancer Centre, Northwood, Not set

Conditions: Colorectal Neoplasms

Learn More ›

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

NCT06736574

Recruiting

The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospitalization, transplantation, or death in patients with heart failure and severely reduced ejection fraction.

Gender:

ALL

Ages:

Between 18 years and 85 years

Trial Updated:

07/17/2025

Locations: Advanced Cardiovascular, LLC, Alexander City, Alabama +62 locations

Advanced Cardiovascular, LLC, Alexander City, Alabama

University of Alabama at Birmingham, Birmingham, Alabama

Pima Heart and Vascular Clinical Research, Tucson, Arizona

National Heart Institute, Beverly Hills, California

UC San Diego Health - Sulpizio Cardiovascular Center, La Jolla, California

Nutrition Research Center (SPH), Loma Linda, California

Keck Medical Center of USC (outpatient clinic), Los Angeles, California

University of California, Irvine Medical Center, Orange, California

Sutter Institute for Medical Research (SIMR), Sacramento, California

San Diego Cardiac Center, San Diego, California

California Pacific Medical Center Van Ness Campus, San Francisco, California

Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center, Torrance, California

Rocky Mountain Regional VA Medical Center, Aurora, Colorado

Cardiology Associates of Fairfield County, P.C, Bridgeport, Connecticut

Hartford Hospital, Hartford, Connecticut

CHF Heart Clinical (Subject Visits & IP Shipments), Clearwater, Florida

Holy Cross Medical Group - Cardiology Associates, Fort Lauderdale, Florida

South Florida Research Solutions, LLC, Hollywood, Florida

UF Health Jacksonville, Jacksonville, Florida

Broward Research Center, Miami Beach, Florida

Ocala Cardiovascular Research, Ocala, Florida

AdventHealth, Orlando, Florida

USF Health South Tampa Center for Advanced Healthcare, Tampa, Florida

Grady Health System, Atlanta, Georgia

Piedmont Fayette Hospital, Fayetteville, Georgia

Midwest Cardiovascular Institute, Naperville, Illinois

Cardiovascular Research of Northwest Indiana, LLC., Munster, Indiana

Deaconess Heart Group, Newburgh, Indiana

Reid Physician Associates, Richmond, Indiana

The University of Kansas Medical Center, Kansas City, Kansas

AHMG Cardiology and Surgery, Overland Park, Kansas

Eastern Main Medical Center dba Northern Light Eastern Maine Medical Center, Bangor, Maine

University of Maryland Medical Center, Baltimore, Maryland

Tufts Medical Center, Boston, Massachusetts

Henry Ford Hospital, Detroit, Michigan

Midwest Heart and Vascular Specialists, LLC, Independence, Missouri

Saint Luke's Hospital of Kansas City, Kansas City, Missouri

Washington University Center for Advanced Medicine, St. Louis, Missouri

St. Louis Heart and Vascular, St. Louis, Missouri

University of Nebraska Medical Center, Omaha, Nebraska

Advanced Heart Care, LLC, Bridgewater, New Jersey

Monmouth Cardiology Associates, LLC, Eatontown, New Jersey

Capital Cardiology Associates, Albany, New York

Montefiore Medical Center (Moses Campus), Bronx, New York

Mount Sinai Hospital, New York, New York

Columbia University Medical Center / New York - Presbyterian, New York, New York

WakeMed Heart & Vascular - Cary Cardiology, Cary, North Carolina

Duke University Hospital, Durham, North Carolina

Moses H. Cone Memorial Hospital Operating Corporation d/b/a Cone Health, Greensboro, North Carolina

The Lindner Research Center at the Christ Hospital, Cincinnati, Ohio

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Cleveland Clinic, Cleveland, Ohio

K&R Research LLC, Marion, Ohio

Capital Area Research, LLC, Camp Hill, Pennsylvania

Medical University of South Carolina - Gazes Research Institute, Charleston, South Carolina

Monument Health Clinical Research, a department of Monument Health Rapid City Hospital, Inc., Rapid City, South Dakota

Stern Cardiovascular Foundation, Inc., Germantown, Tennessee

Tennessee Center for Clinical Trials, Tullahoma, Tennessee

Baylor University Medical Center, Dallas, Texas

Medresearch Inc, El Paso, Texas

Baylor Scott & White Medical Center- The Hearth Hospital, Plano, Texas

Sentara Norfolk General Hospital, Norfolk, Virginia

Medical College of Wisconsin / Froedtert Hospital, Milwaukee, Wisconsin

Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction

Learn More ›

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

NCT06774131

Recruiting

This study will evaluate the efficacy and safety of UGN-104, a new formulation of UGN-101 (approved in the United States and Israel as JELMYTO \[mitomycin\] for pyelocalyceal solution), instilled in the upper urinary tract (UUT) of patients with low-grade upper tract urothelial cancer (LG-UTUC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/17/2025

Locations: BioResearch Partners Aventura, Aventura, Florida +2 locations

Conditions: Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma

Learn More ›

A Study of HARMONIC 700 Shears With Advanced Hemostasis in Pediatric and Adult Surgical Procedures

NCT06608485

Recruiting

The main purpose of this study is to demonstrate acceptable performance and assess safety of the HARMONIC 700 Shears device in a post-market setting when used per the instructions for use in pediatric and adult surgical procedures.

Gender:

ALL

Ages:

110 years and below

Trial Updated:

07/17/2025

Locations: Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana +7 locations

Conditions: Pediatric Surgical Procedures, Adult Surgical Procedures, Adult Gynecological Procedures, Adult Urological Procedures, Adult Thoracic Procedures

Learn More ›

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

NCT06667908

Recruiting

The purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by consolidation immunotherapy (cIT) can improve objective response rate (ORR; that is percentage of participants whose best response is complete response or partial response during the study) in participants with locally advanced and unresectable stage III non-small cell lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/17/2025

Locations: University of Connecticut Health Center, Farmington, Connecticut +10 locations

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

NCT06753916

Recruiting

The main objective of this study is to determine the safety of Ex Vivo Cross Linking (CXL) of donor corneal tissue in participants who have undergone high-risk penetrating keratoplasty.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/17/2025

Locations: University of California Irvine - Gavin Herbert Eye Institute, Irvine, California +9 locations

Conditions: Corneal Transplant Failure

Learn More ›

A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis

NCT06921759

Recruiting

The main purpose of this study is to assess the efficacy of lebrikizumab versus placebo on skin lesions in adults and adolescent participants with atopic hand and foot dermatitis. This study lasts up to 32 weeks, including a 6-week screening period, a 16-week treatment period, and a safety follow-up visit 12 weeks after the last dose.

Gender:

ALL

Ages:

12 years and above

Trial Updated:

07/17/2025

Locations: Medical Dermatology Specialists, Phoenix, Arizona +80 locations

Medical Dermatology Specialists, Phoenix, Arizona

First OC Dermatology Research Inc, Fountain Valley, California

Dermatology Research Associates, Los Angeles, California

Encore Medical Research, Hollywood, Florida

Research Associates of South Florida - Miami - Southwest 8th Street, Miami, Florida

Renstar Medical Research, Ocala, Florida

DeNova Research, Chicago, Illinois

Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana

Southern Indiana Clinical Trials, New Albany, Indiana

Revival Research Institute, LLC, Troy, Michigan

MediSearch Clinical Trials, Saint Joseph, Missouri

Care Access - Hoboken, Hoboken, New Jersey

Optima Research - Boardman, Boardman, Ohio

Progressive Clinical Research, San Antonio, Texas

Texas Dermatology and Laser Specialists, San Antonio, Texas

Complete Dermatology, Sugar Land, Texas

Instituto de Neumonologia Y Dermatologia, Ciudad Autonoma de Buenos Aires, Buenos Aires

Psoriahue, Ciudad Autonoma de Buenos Aires, Buenos Aires

Fundación Respirar, Ciudad Autónoma de Buenos Aires, Buenos Aires

Centro de Investigaciones San Miguel, San Miguel, Buenos Aires

Investigaciones Medicas Imoba Srl, Buenos Aires, Ciudad Autónoma De Buenos Aires

Fundacion Estudios Clinicos, Rosario, Santa Fe

INECO Neurociencias Oroño, Rosario, Santa Fe

Instituto de Investigaciones Clinicas Rosario, Rosario, Santa Fe

CONEXA Investigacion Clinica S.A., Buenos Aires, Not set

CIPREC, Buenos Aires, Not set

Parra Dermatología, Mendoza, Not set

Paratus Clinical Research Woden, Phillip, Australian Capital Territory

St George Dermatology & Skin Cancer Centre, Kogarah, New South Wales

The Skin Centre, Benowa, Queensland

Cornerstone Dermatology, Coorparoo, Queensland

Veracity Clinical Research, Woolloongabba, Queensland

Skin Health Institute Inc., Carlton, Victoria

Institute for Skin, Health and Immunity, Mitcham, Victoria

Fremantle Dermatology, Fremantle, Western Australia

CaRe Clinic, Red Deer, Alberta

Interior Dermatology Centre - Probity - PPDS, Kelowna, British Columbia

Wiseman Dermatology Research Inc., Winnipeg, Manitoba

SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario

DermEffects, London, Ontario

FACET Dermatology, Toronto, Ontario

INTERMED Groupe Sante, Chicoutimi, Quebec

Centre de Recherche Saint-Louis, Montréal, Quebec

Private Practice - Dr. Rachel Asiniwasis, Regina, Saskatchewan

Centre de Recherche Saint-Louis, Quebec, Not set

Kosugi Dermatology Clinic, Kawasaki-shi, Kanagawa

Dermatology and Ophthalmology Kume Clinic, Sakai City, Osaka

Maruyama Dermatology Clinic, Koto-ku, Tokyo

Tanpopo Skin Clinic, Ota, Tokyo

Tokyo Medical University Hospital, Shinjuku-ku, Tokyo

Tachikawa Dermatology Clinic, Tachikawa, Tokyo

University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Not set

Pansy Skin Clinic, Saitama, Not set

The Catholic University of Korea, Incheon St. Mary's Hospital, Bupyeong-gu, Incheon-gwangyeoksi [Incheon]

Chosun University Hospital, Gwangju, Kwangju-Kwangyǒkshi

Korea University Ansan Hospital, Ansan-si, Kyǒnggi-do

Ajou University Hospital, Suwon, Kyǒnggi-do

Pusan National University Yangsan Hospital, Busan, Kyǒngsangnam-do

Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [Seoul]

Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]

Konkuk University Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Kyung Hee University Hospital at Gangdong, Seoul, Seoul-teukbyeolsi [Seoul]

Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]

Kyungpook National University Hospital, Jung-gu, Taegu-Kwangyǒkshi

Cryptex Investigación Clínica S.A. de C.V., Cuauhtémoc, Ciudad De México, Distrito Federal

RM Pharma Specialists, Mexico City, Distrito Federal

Grupo Clínico CATEI S.C., Guadalajara, Jalisco

Instituto Dermatologico de Jalisco, Zapopan, Jalisco

Eukarya Pharmasite S.C., Monterrey, Nuevo León

Kohler & Milstein Research S.A. De C.V., Mérida, Yucatán

Scientia Investigacion Clinica S.C., Chihuahua, Not set

Arké SMO S.A de C.V, Veracruz, Not set

National Taiwan University Hospital - Hsinchu branch, Zhu Bei City, Hsinchu

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist, Kaohsiung

New Taipei Municipal TuCheng Hospital, New Taipei City, New Taipei

Tri-Service General Hospital, Taipei City, Taipei

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Not set

Conditions: Atopic Hand and Foot Dermatitis

Learn More ›

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

NCT06972472

Recruiting

The main purpose of this study is to see how orforglipron, compared with placebo, helps improve glycemic control in participants with obesity or with overweight and type 2 diabetes. This trial is part of the master protocol study J2A-MC-GZPO. Participation in the study will last about 18 months.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/17/2025

Locations: Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson, Arizona +88 locations

Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson, Arizona

Norcal Endocrinology & Internal Medicine, San Ramon, California

Southern California Clinical Research, Santa Ana, California

Care Access - Thousand Oaks, Thousand Oaks, California

Accel Research Sites - DeLand Clinical Research Unit, DeLand, Florida

Innovation Medical Research Center - Fort Lauderdale, Fort Lauderdale, Florida

Encore Medical Research, Hollywood, Florida

West Orange Endocrinology P.A., Ocoee, Florida

Care Access - Tampa, Tampa, Florida

Accel Research Sites - NeuroStudies Clinical Research Unit, Decatur, Georgia

Care Access - Decatur, Decatur, Georgia

Javara - Privia Medical Group Georgia - Savannah, Savannah, Georgia

North Georgia Clinical Research, Woodstock, Georgia

Solaris Clinical Research, Meridian, Idaho

Care Access - New Iberia, New Iberia, Louisiana

Endocrine and Metabolic Consultants, Rockville, Maryland

Javara - Privia Medical Group - Silver Spring, Silver Spring, Maryland

Boeson Research MSO, Missoula, Montana

Javara - Nevada Health Centers - Carson City, Carson City, Nevada

The Machuca Foundation, Las Vegas, Nevada

University of North Carolina Medical Center, Chapel Hill, North Carolina

Javara - Tryon Medical Partners, Charlotte, North Carolina

Care Access - Fayetteville, Fayetteville, North Carolina

The Corvallis Clinic, P.C., Corvallis, Oregon

Clinical Research of Philadelphia, Philadelphia, Pennsylvania

Frontier Clinical Research, LLC, Smithfield, Pennsylvania

Velocity Clinical Research, Dallas, Dallas, Texas

Biopharma Informatic, LLC, Houston, Texas

Texas Valley Clinical Research (TVCR) - Mission, Mission, Texas

Consano Clinical Research, LLC, Shavano Park, Texas

CARE - Centro de Alergia y Enfermedades Respiratorias, Ciudad Autónoma de Buenos Aires, Buenos Aires

CIPREC, Buenos Aires, Ciudad Autónoma De Buenos Aires

Centro Médico Viamonte, Buenos Aires, Ciudad Autónoma De Buenos Aires

Instituto Centenario, Caba, Ciudad Autónoma De Buenos Aires

Instituto Médico Catamarca IMEC, Rosario, Santa Fe

Centro de Diagnóstico y Rehabilitación (CEDIR), Santa Fe, Not set

The Second People's Hospital of Hefei, Hefei, Anhui

Xuanwu Hospital Capital Medical University, Beijing, Beijing

Peking University Third Hospital, Beijing, Beijing

The Second Affiliated Hospital Chongqing Medical University, Chongqing, Chongqing

Zhujiang Hospital, Guangzhou, Guangdong

The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang

The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi, Henan

Zhongda Hospital Southeast University, Nanjing, Jiangsu

The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu

Jinan Central Hospital, Jinan, Shandong

Sichuan Provincial People's Hospital, Chengdu, Sichuan

The Second Hospital of Tianjin Medical University, Tianjin, Tianjin

MUDr. Alena Vachova, Ceske Budejovice, Jihočeský Kraj

VASOMED Clinic, Ostrava, Moravskoslezský Kraj

Milan Kvapil s.r.o., Diabetologicka ambulance, Praha, Praha 4

Medical Plus, Uherske Hradiste, Zlínský Kraj

Nemocnice Cesky Krumlov, Český Krumlov, Not set

Medicover Neuroendokrinologie, Munich, Bayern

InnoDiab Forschung Gmbh, Essen, Nordrhein-Westfalen

Medizentrum Essen Borbeck, Essen, Nordrhein-Westfalen

AmBeNet GmbH, Leipzig, Sachsen

Gemeinschaftspraxis Dr. Taeschner/Dr. Bonigut, Leipzig, Sachsen

RED-Institut GmbH, Oldenburg, Schleswig-Holstein

Diabetes Zentrum Wilhelmsburg, Hamburg, Not set

Apollo Excelcare Hospital, Guwahati, Assam

Sir Ganga Ram Hospital, New Delhi, Delhi

Karnataka Institute of Medical Sciences, Hubli, Karnataka

Chellaram Diabetes Institute, Pune, Maharashtra

All India Institute of Medical Sciences, Bhubaneswar, Odisha

Diabetes Research Center, Hyderabad, Telangana

All India Institute of Medical Sciences - Rishikesh, Rishikesh, Uttarakhand

Tokuyama Clinic, Mihama-ku,Chiba City, Chiba

Hasegawa Medicine Clinic, Chitose, Hokkaido

Tsuchiura Medical & Health Care Center, Tsuchiura, Ibaraki

Noritake Clinic, Ushiku, Ibaraki

Olive Takamatsu Medical Clinic, Takamatsu, Kagawa

Medical Corporation Yuga Tsuruma Kaneshiro Diabetes Clinic, Yamato-shi, Kanagawa

Yokohama Minoru Clinic, Yokohama, Kanagawa

Medical Corporation Heishinkai OCROM Clinic, Suita-shi, Osaka

The Institute of Medical Science, Asahi Life Foundation, Chuo-ku, Tokyo

Tokyo-Eki Center-building Clinic, Chuo-ku, Tokyo

Fukuwa Clinic, Chuo-ku, Tokyo

Medical Corporation Heishinkai ToCROM Clinic, Shinjuku-ku, Tokyo

Shimokitazawa Tomo Clinic, Tokyo, Not set

RM Pharma Specialists - Unidad Especializada en Datos, Mexico City, Distrito Federal

Endocrinologia Especializada, Mexico, Distrito Federal

Diseno y Planeacion en Investigacion Medica - Guadalajara - Calle Amado Nervo, Guadalajara, Jalisco

Centro Medico Zambrano Hellion, San Pedro Garza Garcia, Nuevo León

Medical Care and Research SA de CV, Merida, Yucatán

Kohler & Milstein Research S.A. De C.V., Mérida, Yucatán

Enclifar Ensayos Clínicos Farmacológicos Sc, Chihuahua, Not set

Puerto Rico Health and Wellness Institute, Dorado, Not set

Isis Clinical Research Center, Guaynabo, Not set

Conditions: Obesity, Overweight, Type 2 Diabetes

Learn More ›

Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy

NCT06554288

Recruiting

This study looks at how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy. The study aims to understand how trihexyphenidyl is broken down and used in the body of pediatric patients and whether this is impacted by a person's genetics. Information from this study will also be used to design future clinical trials.

Gender:

ALL

Ages:

Between 5 years and 17 years

Trial Updated:

07/17/2025

Locations: Children's Mercy Hospital Kansas City, Kansas City, Missouri

Conditions: Pediatric Disorder, Genetic Predisposition, Dystonia, Secondary, Dystonia, Cerebral Palsy, Dystonic-Rigid, Cerebral Palsy, Dyskinetic, Trihexyphenidyl Adverse Reaction, Pharmacogenomic Drug Interaction

Learn More ›

The Advancing Dynamic And Personalized Training Study

NCT07051330

Recruiting

This study aims to enhance the Healthy Minds Program (HMP) app by developing and testing a personalized, data-driven approach to optimize long-term well-being. 1100 participants will be enrolled and on study for up to 4 months (4 week intervention plus 3 month follow-up).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/17/2025

Locations: Center for Healthy Minds, Madison, Wisconsin

Conditions: Well-Being, Psychological

Learn More ›

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Recruiting

Researchers are looking for a better way to treat people who have solid tumors with HER2-activating mutations. Before a treatment can be approved for people to take, researchers do clinical trials to better understand its safety and how it works. In this trial, the researchers want to learn how well BAY2927088 (sevabertinib) works in people with different types of solid tumors with HER2 mutations. These include tumors in the colon or rectum, the uterus and the cervix (lower part of the uterus),... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/17/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +53 locations

University of Alabama at Birmingham, Birmingham, Alabama

City of Hope - Duarte Cancer Center, Duarte, California

Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers, Florida

Dana-Farber Cancer Institute - Oncology Department, Boston, Massachusetts

Brigette Harris Cancer Pavilion at Henry Ford Cancer Center - Detroit, Detroit, Michigan

Profound Research -OMG - TriAtria Cancer Center, Farmington Hills, Michigan

Cleveland Clinic - Oncology Department, Cleveland, Ohio

SCRI Oncology Partners, Nashville, Tennessee

University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston, Texas

University of Washington Medical Center (UWMC) - Montlake - Gynecology Oncology, Seattle, Washington

UW Health - UW Carbone Cancer Center - Medical Oncology Clinic, Madison, Wisconsin

Blacktown Cancer & Haematology Centre, Blacktown, New South Wales

Macquarie University Hospital - Oncology Department, Sydney, New South Wales

ICON Cancer Centre - Southport, Southport, Queensland

Queen Elizabeth II Health Sciences Centre - Victoria General Site, Halifax, Nova Scotia

Princess Margaret Cancer Centre - University Health Network - Department of Medical Oncology and Hematology, Toronto, Ontario

McGill University Health Centre - Glen Site, Montreal, Quebec

Peking University First Hospital - Oncology Department, Beijing, Beijing

Beijing Cancer Hospital - Oncology Department, Beijing, Beijing

Hunan Cancer Hospital - Oncology Department, Changsha, Hunan

Zhongshan Hospital, Fudan University - Oncology Department, Shanghai, Shanghai

Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department, Hangzhou, Zhejiang

Fudan University Shanghai Cancer Center - Oncology Department, Shanghai, Not set

Aarhus University Hospital - Oncology Department, Aarhus N, Not set

Rigshospitalet - Kræftbehandling, Copenhagen, Not set

Odense University Hospital - Oncology Department, Odense C, Not set

Institut Bergonie - Unicancer Nouvelle Aquitaine - Service Oncologie medicale, Bordeaux, Not set

CHU Brest - Hopital La Cavale Blanche - service oncologie medicale, Brest, Not set

Centre Oscar Lambret - Service Oncologie, Lille, Not set

Institut du Cancer Montpellier (ICM), Montpellier, Not set

Centre Hospitalier Lyon Sud - Service oncologie medicale, Pierre-Benite, Not set

Institut Gustave Roussy - Departement d'Innovation Therapeutique et d'Essais Precoces (DITEP), Villejuif Cedex, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori - S. C. Oncologia Medica 1, Milano, Not set

Istituto Europeo di Oncologia s.r.l - Ginecologia Oncologica Medica, Milano, Not set

Azienda USL IRCCS di Reggio Emilia_Arcispedale Santa Maria Nuova - S.C. Oncologia Provinciale, Reggio Emilia, Not set

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Oncologia Medica, Roma, Not set

Aichi Cancer Center Hospital, Nagoya, Aichi

National Cancer Center Hospital East (NCCHE) - Kashiwa Campus, Kashiwa, Chiba

Hokkaido University Hospital, Sapporo, Hokkaido

Kindai University Hospital, Osakasayama, Osaka

National Cancer Center Hospital, Chuo-ku, Tokyo

The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo

Severance Hospital, Yonsei University Health System - Oncology Department, Seoul, Seoul Teugbyeolsi

Asan Medical Center - Oncology Department, Seoul, Seoul Teugbyeolsi

Seoul National University Hospital, Seoul, Seoul Teugbyeolsi

Samsung Medical Center - Oncology Department, Seoul, Not set

Institut Catala d'Oncologia (ICO) - Hospital Duran i Reynals - Oncology Department, L'Hospitalet de Llobregat, Barcelona

Clinica Universidad de Navarra-Oncology Service, Madrid, Navarra

Hospital Quiron Dexeus - Oncologia, Barcelona, Not set

Hospital Universitari Vall d'Hebron- Oncology Service, Barcelona, Not set

Hospital Universitario Fundacion Jimenez Diaz- Oncology Service, Madrid, Not set

Inselspital Bern - Universitätsklinik für Medizinische Onkologie, Bern, Not set

Hopitaux Universitaires de Geneve - Oncology Department, Genève, Not set

Univestitätsspital Zürich (USZ), Zürich, Not set

Conditions: Advanced Solid Tumors, HER2 Mutation

Learn More ›